NCT05970029

Brief Summary

Effective management of postoperative pain is a priority for women undergoing cesarean delivery. Despite availability of modern analgesics, postoperative pain management remains a challenge. One opportunity to enhance the analgesic effect of the pharmacological treatments given to people suffering from pain (and not just pain) is through increasing the expectations for pain relief following treatment. Although much knowledge has been accumulated about the significant effect of expectations on pain, virtually all evidence are based on experimental studies carried out in laboratory settings, and there is a need to investigate how this knowledge could translated into improved clinical care. The aim of the current study is to examine whether the communication style between the nursing staff and the patient during analgesic administration will affect the results of pain relief treatment in the mother-newborn ward after cesarean section. As another goal, the study will examine whether relevant patient's characteristics will predict the effectiveness of the treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

August 1, 2023

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

April 20, 2023

Last Update Submit

July 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity on the 0-10 pain scale

    Change in pain intensity one hour following administration of analgesics

    one hour

Other Outcomes (2)

  • The Self-Consciousness Scale (SCS-R)

    Once, at baseline

  • The Short suggestibility scale (SSS)

    Once, at baseline

Study Arms (2)

Enhanced communication

EXPERIMENTAL

In the enhanced communication study arm the nurse will say to the patient: "I will now give you our first line analgesic medication, liquid Dipyrone. It is a very efficient treatment and based on my experience you will very soon feel significant pain relief".

Behavioral: Communication style

Normal communication

OTHER

In the normal communication study arm the communication between the nurse and patients will be as usual in clinical practice - i.e. - no instruction are given to the nurses regarding on how to communicate with patients while administrating the treatment.

Behavioral: Communication style

Interventions

The verbal communication between the nurse and the patient at the time of analgesic administration

Enhanced communicationNormal communication

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly woman undergoing cesarian section
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Be able to provide signed and dated written informed consent and to be compliant with the schedule of protocol assessments.
  • Females aged 18 till 50
  • Undergoing cesarean section

You may not qualify if:

  • \* Mental retardation and cognitive impairment
  • study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, Israel

RECRUITING

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Vered Cohen, BA

    Carmel Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vered Cohen, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
At the time of analgesic request the nurse will open an envelop in which the participant assignment will be described. While the nurse (the communicator) is not blinded, the participants are blinded. The pain intensity reports will be recoded by the participants via a secured link, hence the participants are also the outcome assessor.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Parallel design - subjects are allocated into one of two study arms
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2023

First Posted

August 1, 2023

Study Start

June 1, 2023

Primary Completion

January 1, 2024

Study Completion

March 1, 2024

Last Updated

August 1, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

A link to the data location will be published in the article summarizing the results

Locations